FrederickMFellinMD
Oncology • Philadelphia, PABreast Cancer, Hematologic Oncology
Assistant Professor of Medicine, Thomas Jefferson University
Dr. Fellin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
925 Chestnut St
Suite 420
Philadelphia, PA 19107Phone+1 215-955-8874
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1988 - 1989- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1985 - 1988
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1980 - 1983
West Virginia UniversityInternship, Transitional Year, 1979 - 1980- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1979
Certifications & Licensure
PA State Medical License 1981 - 2026
DE State Medical License 2017 - 2025
NJ State Medical License 2017 - 2023
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer Start of enrollment: 2011 Dec 01
- Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax Start of enrollment: 2013 May 21
- Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer Start of enrollment: 2013 Apr 25
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsGenomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism.Maysa Abu-Khalaf, Chun Wang, Zhenchao Zhang, Rui Luo, Weelic Chong
Cancers. 2022-06-10 - 30 citationsPrognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.Chun Wang, Zhaomei Mu, Zhong Ye, Zhenchao Zhang, Maysa M. Abu-Khalaf
Breast Cancer Research and Treatment. 2020-05-04 - 35 citationsAssociation of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.Zhong Ye, Chun Wang, Shaogui Wan, Zhaomei Mu, Zhenchao Zhang
European Journal of Cancer. 2019-01-01
Professional Memberships
- Fellow
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
